The discovery of two distinct ‘hot’ inflamed tumor clusters (total 19.6%) within our HGSOC cohort with the best patient survivals, but with opposing high or low ERV‐L1 expression is novel and supports different IFN signaling. This evidence concerns the gene IFNA1 and neoplasm.